go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

North Dakota rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $562,341 · 10th–90th $562,341$1,023,2930%50%90th$562,341Professionalmedian $562,341 · 10th–90th $562,341$851,1380%50%90th$562,341$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$1,023,292.99
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Cigna
Setting
Professional
Modifier
Global
Typical Low
$524,807.46
Median
$537,031.80
Typical High
$676,082.98
Medica
Setting
Facility
Modifier
Global
Typical Low
$537,031.80
Median
$851,138.04
Typical High
$1,819,700.86
Medica
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
United
Setting
Facility
Modifier
Global
Typical Low
$616,595.00
Median
$616,595.00
Typical High
$616,595.00
United
Setting
Professional
Modifier
Global
Typical Low
$407,380.28
Median
$512,861.38
Typical High
$851,138.04